Vitamin E : Atherosclerosis
C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。Strong mechanistic rationale (LDL oxidation inhibition) but large RCTs (HOPE, GISSI-Prevenzione) show no benefit. Meta-analysis suggests potential harm at >=400 IU/day. AHA does not recommend supplementation.
結論
Strong mechanistic rationale (LDL oxidation inhibition) but large RCTs (HOPE, GISSI-Prevenzione) show no benefit. Meta-analysis suggests potential harm at >=400 IU/day. AHA does not recommend supplementation.
Key Study Findings
対象集団: Review of anti-atherosclerotic supplements and bleeding
対象集団: None
対象集団: None
対象集団: Aging adults (nutrition and cognition)
対象集団: Patients with atopic dermatitis
対象集団: None
Key Statistics
15
研究数
50000
参加者数
Mixed
グレード
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- note:
- High-dose supplementation no longer recommended based on clinical trial evidence
- general:
- 15 mg/day (22.4 IU)
上限量: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
推奨摂取タイミング: With meals containing fat
Safety & Side Effects
報告されている副作用
- ⚠ Increased bleeding risk at high doses
- ⚠ Possible increased all-cause mortality at >=400 IU/day
- ⚠ Increased heart failure hospitalization risk (HOPE/HOPE-TOO)
- ⚠ Nausea, diarrhea, fatigue at high doses
既知の相互作用
- ● Anticoagulants (increased bleeding risk)
- ● Statins and niacin (may blunt HDL-raising effect)
- ● Chemotherapy and radiation (theoretical interference with oxidative mechanisms)
- ● Vitamin K (may antagonize at high doses)
耐容上限摂取量: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Vitamin E help with Atherosclerosis?
How much Vitamin E should I take for Atherosclerosis?
Are there side effects of Vitamin E?
How strong is the evidence for Vitamin E and Atherosclerosis?
Related Evidence
に関する他の成分: Atherosclerosis
References
- [1] Maria-Zinaida Dobre et al.. Int J Mol Sci. 2025. Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks. doi:10.3390/ijms262010183 PubMed
- [2] Eiji Yamashita. Adv Exp Med Biol. 2021. Extensive Bioactivity of Astaxanthin from Haematococcus pluvialis in Human. doi:10.1007/978-981-15-7360-6_23 PubMed
- [3] Raúl Francisco Pastor et al.. Nutrients. 2020. Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome. doi:10.3390/nu12103149 PubMed
- [4] Katherine L Tucker. Ann N Y Acad Sci. 2016. Nutrient intake, nutritional status, and cognitive function with aging. doi:10.1111/nyas.13062 PubMed
- [5] N Sivaranjani et al.. J Clin Diagn Res. 2013. Role of reactive oxygen species and antioxidants in atopic dermatitis. doi:10.7860/JCDR/2013/6635.3732 PubMed
- [6] Fredric J Pashkow et al.. Am J Cardiol. 2008. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. doi:10.1016/j.amjcard.2008.02.010 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。